Related Experiment Videos
The promoter and 5' flanking sequences controlling human B29 gene expression
A A Thompson1, W J Wood, M J Gilly
1Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratories, Los Angeles, CA, USA.
Blood
|January 15, 1996
Summary
The B29 gene, crucial for B-cell activation, is regulated by a complex interplay of DNA elements. A novel B29 conserved sequence (BCS) counteracts negative regulatory elements, enhancing B-cell-specific transcription.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- The B29 gene (also known as Ig beta or CD79b) is vital for B-cell antigen receptor (BCR) complex function and B-cell activation.
- Understanding B29 gene regulation is key to deciphering B-cell signaling pathways.
Purpose of the Study:
- To investigate the transcriptional control elements regulating the human B29 gene.
- To identify and characterize novel regulatory motifs within the upstream genomic DNA of the B29 gene.
Main Methods:
- Analysis of human genomic DNA sequences upstream of the B29 gene's ATG start codon.
- Identification of transcription factor binding motifs (SP1, ETS, OCT, IKAROS/LYF-1) within the minimal promoter region.
- Characterization of a newly identified motif, the B29 conserved sequence (BCS).
Main Results:
- The human B29 gene promoter lacks TATA/CAAT boxes and exhibits multiple transcription start sites.
- A 193-bp minimal promoter region confers B-cell-specific activity and contains conserved transcription factor motifs.
- A novel BCS motif enhances B29 transcription by overcoming negative regulatory elements.
Conclusions:
- B29 gene expression is tightly controlled by a sophisticated balance of positive and negative regulatory DNA sequences.
- The BCS motif plays a significant role in B29 gene regulation through a unique mechanism.
- These findings provide insights into the molecular mechanisms governing B-cell activation and function.